Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

diabetes-2424105_960_720

Study identifies five kinds of diabetes, potentially changing treatment

March 2, 2018 Medical Communications, Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

A decade-long study has unearthed findings that could entirely change how people living with diabetes are treated, after the classic …
News
phone_health

Novartis forms a Pear to develop mobile therapies

March 2, 2018 Medical Communications, Research and Development Novartis, Pear Therapeutics, biotech, drugs, pharma, pharmaceutical

Novartis has announced an agreement between Pear Therapeutics and itself to develop two digital therapeutics, one in schizophrenia and one …
News
david_meek_web

Ipsen: Becoming a “development powerhouse”

March 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Insider Interview, ipsen, pharma

Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …
Feature

Europe approves first therapy for haemophilia A with inhibitors in over 20 years

March 1, 2018 Research and Development Europe, European Commission, Hemlibra, Roche, haemophilia, pharma

Roche has revealed that its bispecific factor IXa- and factor X-directed antibody Hemlibra (emicizumab) has been approved by the European …
News
anatomy-3003099_960_720

Stem cell therapy offers hope for spinal cord injuries

February 28, 2018 Research and Development biotech, drugs, pharma, pharmaceutical, stem cell, stem cell treatment

Scientists have brought the prospect of spinal cord injuries being able to be treated with stem cells one step closer, …
News
celgene_1_02

FDA refuses to review Celgene’s ozanimod in multiple sclerosis

February 28, 2018 Research and Development, Sales and Marketing Celgene, FDA, multiple sclerosis, ozanimod, pharma

Celgene has been dealt a heavy blow, revealing that the FDA has rejected its New Drug Application for its sphingosine …
News

AstraZeneca creates biotech spin-off, $250m in bank

February 28, 2018 Research and Development, Sales and Marketing AstraZeneca, Viela, biotech, drugs, pharma, pharmaceutical

Biotechs created from big pharma companies tend to have an easier start to life than most, and this is definitely …
News
pharmafocus_march_2018_cover

Pharmafocus March 2018 is available to read online now!

February 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, brexit, drug safety, pharma, real world data

Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …
News
dna

Generation Bio backed with $100m financing round

February 28, 2018 Research and Development, Sales and Marketing Generation Bio, biotech, drugs, pharma, pharmaceutical

At the start of year, Generation Bio was revealed to the public, announcing that it had been developing gene therapies …
News
opioid_crisis

FDA to fight opioid crisis with wider access to medication-assisted treatment

February 27, 2018 Manufacturing and Production, Medical Communications, Research and Development Alex Azar, FDA, medication-assisted treatment, opioid crisis, opioids, pharma

The FDA is set to refocus its efforts in combating the United States’ opioid crisis. Speaking at a meeting of …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Alzheimer's, AstraZeneca, Eylea, FDA, Microsoft, Regeneron, Shire, Tremfya, eurordis, multiple myeloma, rare disease

It’s the last Friday of February, and it’s time for another run-down of the most popular stories of the week. …
News
tumour_growing_jan-chlebik-for-the-icr-2013

Lab-grown tumours able to predict drug efficacy

February 23, 2018 Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical

One of the key challenges facing the treatment of cancer is knowing whether a particular drug will work with an …
News

Novo Nordisk delivers in much-anticipated oral semaglutide diabetes trial

February 23, 2018 Medical Communications, Research and Development Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes

Novo Nordisk has lifted the curtain on much-anticipated results data from the first of ten Phase 3 trials into the …
News
aaa

Insider Interview: Allergan’s R&D Chief on plans to be “the headache company”

February 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, David Nicholson, Insider Interview, migraine, pharma

Speaking to Pharmafocus , David Nicholson, Chief R&D Officer at Allergan, revealed that the company has big plans in the …
Feature
regeneron

Reports increasing of worrying side-effects with Regeneron’s Eylea

February 22, 2018 Medical Communications, Research and Development, Sales and Marketing Eylea, FDA, Regeneron, pharma

Reports are emerging which detail some pretty alarming side-effects in patients receiving Regeneron’s blockbuster eye drug Eylea: once injected into …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025